The assessment of RBE effects using the concept of biologically effective dose

International Journal of Radiation Oncology Biology Physics

Volumn 43, Issue 3, 1999, Pages 639-645

  Dale, Roger G ^a   Jones, Bleddyn ^b  

^a CHARING CROSS HOSPITAL   (United Kingdom)

^b CLATTERBRIDGE CENTRE FOR ONCOLOGY   (United Kingdom)

Author keywords

Biologically effective dose; Fractionation effects; High LET radiation; Linear quadratic model; Radiobiological modeling; Relative biological effectiveness

Indexed keywords

ANIMAL TISSUE; ARTICLE; CANCER RADIOTHERAPY; MATHEMATICAL MODEL; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIOBIOLOGY; TUMOR GROWTH;

EID: 0033048040     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(98)00364-2     Document Type: Article

References (29)

1. Kellerer A.M., Rossi H.H. A generalized formulation of dual radiation action. Rad Res. 75:1978;471-488.
2. Joiner M.C., Bremner J.C., Denekamp J., Maughan R.L. The interaction between X-rays and neutrons in the skin of the mouse foot. Int J Radiat Biol. 46:(5):1984;6125-6138.
3. Joiner M.C., Johns H. Renal damage in the mouse The effect of d(4)-Be neutrons . Rad Res. 109:1987;456-468.
4. Carlsson J., Stenerlöw B., Russell K., Grusell E., Larsson B., Blomquist E. Cell type dependent effectiveness of tumor cell inactivation by radiation with increased ionization density. Anticancer Res. 15:1995;273-282.
5. Joiner M.C., Field S.B. The response of mouse skin to irradiation with neutrons from the 62MV cyclotron at Clatterbridge, UK. Radiother Oncol. 12:1988;153-166.
6. Gasinska A., Dubray B., Hill S.A., Denekamp J., Thames H.D., Fowler J.F. Early and late injuries in mouse rectum after fractionated X-ray and neutron irradiation. Radiother Oncol. 26:1993;244-253.
7. Barendsen G.W. Dose fractionation, dose rate and iso-effect relationships for normal tissue response. Int J Radiat Oncol Biol Phys. 8:1982;1981-1997.
8. Dale R.G. The application of the linear-quadratic dose-effect equation to fractionated and protracted radiotherapy. Br J Radiol. 58:1985;515-528.
9. Dale R.G., Huczcowski J., Trott K.R. Possible dose rate dependence of recovery kinetics as deduced from a preliminary analysis of the effects of fractionated irradiations at varying dose rates. Br J Radiol. 61:1988;153-157.
10. Dale R.G., Jones B., Coles I.P. The effect of tumor shrinkage on the biological effectiveness of permanent brachytherapy implants. Br J Radiol. 67:1994;639-645.
11. Dale R.G., Jones B. The effect of tumor shrinkage on biologically effective dose, and possible implications for fractionated high dose-rate brachytherapy. Radiother Oncol. 33:1994;125-132.
12. Travis E.L., Tucker S.L. Iso-effect models and fractionated radiotherapy. Int J Radiat Oncol Biol Phys. 13:1987;283-287.
13. Arslan N.C., Geard C.R., Hall E.J. Low dose-rate effects of cesium-137 and iodine-125 on cell survival, cell progression and chromosomal alterations. Am J Clin Oncol. 9:(6):1986;521-526.
14. 125I sources. II Determination of the relative biological effectiveness using cultured mammalian cells . Int J Radiat Oncol Biol Phys. 1:1985;141-152.
15. Hawkins R.B. A statistical theory of cell killing by radiation of varying linear energy transfer. Rad Res. 140:1994;366-374.
16. Ling C.C., Li W.X., Anderson L.L. The relative biological effectiveness of I-125 and Pd-103. Int J Radiat Oncol Biol Phys. 32:(2):1995;373-378.
17. Marchese M.J., Goldhagen P.E., Zaider M., Brenner D., Hall E.J. The relative biological effectiveness of photon radiation from encapsulated iodine-125, assessed in cells of human origin I Normal diploid fibroblasts . Int J Radiat Oncol Biol Phys. 18:(6):1990;1407-1413.
18. Plume C.A., Daly S.E., Porter A.T., Barnett R.B., Battista J.J. The relative biological effectiveness of ytterbium-169 for low dose-rate of cultured mammalian cells. Int J Radiat Oncol Biol Phys. 25:1993;835-840.
19. Stenerlöw B., Petterson O.-A., Essand M., Blomquist E., Carlsson J. Irregular variations in radiation sensitivity when the linear energy transfer is increased. Radiother Oncol. 36:1995;133-142.
20. Withers H.R., Thames H.D., Peters L.J. Biological bases for high RBE values for late effects of neutron irradiation. Int J Radiat Oncol Biol Phys. 8:1982;2071-2076.
21. (p → Be+) neutrons of human cells differing in photon sensitivity. Int J Radiat Biol. 61:(6):1992;805-812.
22. Broerse J.J., Barendsen G.W. Relative biological effectiveness of fast neutrons for effects on normal tissues. Curr Topics Radiat Res Quart. 8:1973;305-350.
23. Fertil B., Deschavanne P.J., Gueulette J., Possoz A., Wambersie A., Malaise E.P. In vitro radiosensitisation of six human cell lines. II Relation to the RBE of 50 MeV neutrons. Rad Res. 90:1982;526-537.
24. Schmitt G., Wambersie A. Review of the clinical results of fast neutron therapy. Radiother Oncol. 17:1990;47-56.
25. Austin-Seymour M., Caplan R., Russell K., Laramore G., Jacky J., Wootton P., Hummell S., Lindsley K., Griffin T. Impact of multileaf collimator on treatment morbidity in localized carcinoma of the prostate. Int J Radiat Oncol Biol. 30:1994;1065-1071.
26. Scalliet P., Wambersie A. Which RBE for iodine 125 in clinical applications? Radiother Oncol. 9:1987;221-230.
27. Bonnett D.E., Kacperek A., Sheen M.A., Goodall R., Saxton T.E. The 62MeV proton beam for the treatment of ocular melanoma at Clatterbridge. Br J Radiol. 66:1993;907-914.
28. Ling C.C., Fuks Z. Conformal radiation treatment A critical appraisal . Eur J Cancer. 31A:(5):1995;799-803.
29. Jones B., Tan L.T., Dale R.G. Derivation of the optimum dose per fraction from the linear-quadratic model. Br J Radiol. 68:1995;894-902.